These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 33247706)
1. Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma. Jaikumarr Ram A; Girija As S; Jayaseelan VP; Arumugam P Asian Pac J Cancer Prev; 2020 Nov; 21(11):3435-3439. PubMed ID: 33247706 [TBL] [Abstract][Full Text] [Related]
2. Identification of a Novel Epithelial-Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC. Xin W; Zhao C; Jiang L; Pei D; Zhao L; Zhang C Pathol Oncol Res; 2021; 27():585192. PubMed ID: 34257533 [TBL] [Abstract][Full Text] [Related]
3. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma. Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628 [TBL] [Abstract][Full Text] [Related]
4. Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis. Liu Z; Liu H; Dong Q; Li H; Zhang B; Liu Y; Zhong L; Tang H BMC Cancer; 2021 Aug; 21(1):951. PubMed ID: 34433433 [TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic potential of PLEK2 in head and neck squamous cell carcinoma based on bioinformatics analysis. Wang J; Sun Z; Wang J; Tian Q; Huang R; Wang H; Wang X; Han F Cancer Med; 2021 Sep; 10(18):6515-6533. PubMed ID: 34331382 [TBL] [Abstract][Full Text] [Related]
6. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma. Li B; Zhu J; Meng L Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476 [TBL] [Abstract][Full Text] [Related]
7. Retinol-binding protein type 1 expression predicts poor prognosis in head and neck squamous cell carcinoma. Fu LL; Yan M; Yu X; Shao M; Gosau M; Friedrich RE; Vollkommer T; Smeets R; Feng HC; Xu L BMC Cancer; 2024 Oct; 24(1):1277. PubMed ID: 39407127 [TBL] [Abstract][Full Text] [Related]
8. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma. Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179 [TBL] [Abstract][Full Text] [Related]
9. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. Chen L; He X; Yi S; Liu G; Liu Y; Ling Y Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816 [TBL] [Abstract][Full Text] [Related]
10. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus. Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766 [TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas. Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606 [TBL] [Abstract][Full Text] [Related]
12. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis. Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621 [TBL] [Abstract][Full Text] [Related]
13. UBE2C promotes the progression of head and neck squamous cell carcinoma. Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma. Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811 [TBL] [Abstract][Full Text] [Related]
15. A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma. Xu L; Li YY; Zhang YC; Wu YX; Guo DD; Long D; Liu ZH Dis Markers; 2021; 2021():5759927. PubMed ID: 34853622 [TBL] [Abstract][Full Text] [Related]
16. ITGA5 is associated with prognosis marker and immunosuppression in head and neck squamous cell carcinoma. Liu J; Wang Y; Chen X; Chen X; Zhang M Diagn Pathol; 2024 Oct; 19(1):134. PubMed ID: 39375732 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of TPD52L2 in HNSCC: prognostic significance and correlation with immune infiltrates. Lu M; Xia H; Xu J; Liao Z; Li Y; Peng H BMC Oral Health; 2024 Oct; 24(1):1191. PubMed ID: 39375696 [TBL] [Abstract][Full Text] [Related]
18. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods. Jin Y; Yang Y Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688 [TBL] [Abstract][Full Text] [Related]
19. FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC. Liu J; Ouyang Y; Xia Z; Mai W; Song H; Zhou F; Shen L; Chen K; Li X; Zhuang SM; Liao J Cell Oncol (Dordr); 2024 Apr; 47(2):623-638. PubMed ID: 37856075 [TBL] [Abstract][Full Text] [Related]
20. The Clinical Significance of Dickkopf Wnt Signaling Pathway Inhibitor Gene Family in Head and Neck Squamous Cell Carcinoma. Hu Y; Liu M; Xu S; Li S; Yang M; Su T; Yuan Z; Peng H Med Sci Monit; 2020 Nov; 26():e927368. PubMed ID: 33281184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]